anti-VEGF-165b (IsomAb)

N/A

Report date: 2025/06/11 10:45:20

Base Information

Drug Nameanti-VEGF-165b (IsomAb)
Drug Alias Nameanti-VEGF-165b (IsomAb)ISM-001 (IsomAb)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2Peripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsomAb Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIsomAb Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2Peripheral Vascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A